Tuberculosis-HIV Co-infection

HIV/TB coinfection is the combination of HIV and TB infection. Those with HIV have a higher risk of developing TB disease from an untreated latent TB infection than do people without HIV. TB illness is regarded as an AIDS-defining condition in patients with HIV.Conditions that constitute AIDS include infections and cancers that provide a life-threatening hazard to HIV-positive people.
HIV treatment is referred to as antiretroviral therapy (ART). HIV medications boost the immune system, preventing the spread of HIV and AIDS-related illnesses (AIDS). Treatment with HIV and TB medications minimizes the likelihood that latent TB infection may progress to TB illness in patients with HIV and latent TB infection.

    Related Conference of Tuberculosis-HIV Co-infection

    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic

    Tuberculosis-HIV Co-infection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in